News & Media
Main Menu
Presentations
- All PRESENTATIONS
- AZP-3813
- Eneboparatide (AZP-3601)
All PRESENTATIONS
- All PRESENTATIONS
- AZP-3813
- Eneboparatide (AZP-3601)
Eneboparatide (AZP-3601)
Increased bone fragility over time in women with chronic hypoparathyroidism: Real-world data from the HypoparaNet Italian Cohort. ECE 2024 Presentation
Written by
Dan Hennings
Eneboparatide (AZP-3601)
A Translational Approach to Investigate the Mechanism Whereby Eneboparatide Induces Prolonged Calcium Normalization in Patients with Chronic Hypoparathyroidism. ECE 2024 Presentation
Written by
Dan Hennings
Eneboparatide (AZP-3601)
Skeletal Effects among Pre and Postmenopausal Women with Hypoparathyroidism (HypoPT): Data from the Canadian National Hypoparathyroidism Registry (CNHR). ENDO 2024 Poster
Written by
Dan Hennings
Eneboparatide (AZP-3601)
Increased Fragility of Bone Over Time in Female Patients With Chronic Hypoparathyroidism: Real-world Data from the Italian Cohort. Endo 2024 Poster
Written by
Dan Hennings
Eneboparatide (AZP-3601)
Eneboparatide, a potent stimulator of urinary calcium reabsorption, induces prolonged renal cortex retention and PTH1 receptor signaling. Endo 2024 Presentation
Written by
Dan Hennings
Upcoming events
26th European Congress of Endocrinology (ECE)
Date: May 11-14, 2024 (Stockholm, Sweden)
World Hypoparathyroidism Awareness Day
Date: June 1, 2024
2024 Endocrine Society Meeting (ENDO)
Date: June 1-4, 2024 (Boston, MA)
BIO International Convention
Date: June 3-6, 2024 (San Diego, CA)
American Society for Bone and Mineral Research 2024 Annual Meeting (ASBMR)
Date: September 27-30, 2024 (Toronto, Canada)
40th Congress of the French Society of Endocrinology
Date: October 16-18, 2024 (Clermont-Ferrand, France)
Acromegaly Awareness Day
Date: November 1, 2024
Social Updates
TWITTER